In breast cancer, cyclin D1 amplification and CDK4 copy gain are common in luminal and HER2-enriched subtypes but are rare in basal-like tumors with Rb loss or mutation and cyclin E1 amplification 5. This evidence concerns the gene CDK4 and breast carcinoma.